Regencell Bioscience Holdings Limited Ordinary Shares

Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. The company employs 12 full-time employees The company went IPO on 2021-07-16. The firm launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.

Companies that follow Islamic principles, avoiding sectors like alcohol, gambling, and interest-based finance

Sharia-compliant stocks

tag_title_stock_halal

Companies advancing medical treatments and health services

Healthcare

tag_title_stock_sector_healthcare

Invest in 4,500+ global stocks on NASDAQ and NYSE with zero fees

Stocks

tag_title_kind_stock

Top gainers

tag_title_stock_top_gainers

About ETF

About

Analysts estimates

stock is expected to perform in line with the market

stock may significantly underperform the market

Hold

stock may slightly underperform the market

Sell

stock may significantly outperform the market

Strong buy

Strong sell

The average rating from top {analystCount, plural, =0 {# analysts} one {# analyst} other {# analysts}} indicates that <coloredText>{ratingText}</coloredText>

Consensus rating

Dividends

{date} net income

{date} revenue

{date} est. EPS

Previous EPS

Earnings

What’s in the fund

Key stats

View the latest price, performance metrics, and analysis of {assetName}. ({assetSymbol}). Check market data, historical performance, and dividend yields.

{assetName}. ({assetSymbol}) - Stock Overview | {appName}

Check live price data and analysis for {assetName}. ({assetSymbol}). Stay updated on the latest performance metrics.

{assetName}. ({assetSymbol}) Stock Performance and Analysis

The top {analystCount, plural, =0 {# analysts} one {# analyst} other {# analysts}} forecasts that 12-month <coloredText>{prediction}</coloredText>, with a low of {lowPrice} and a high of {highPrice}

Avg. price target

Day’s Range

52W Range

Valuation score

Valuation

Most viewed this week

Confirm PIN

Account with this email already existing. Change phone number to log in to the existing account or contact support.

By continuing, you agree to our <termsAndConditionsLink>Terms & Conditions</termsAndConditionsLink>{br}and acknowledge our <privacyPolicyLink>Privacy Policy</privacyPolicyLink>

What’s your email?

Sent to {contact}.{br}If it’s not showing, check the Spam folder.

Enter the code

Whether you’re new or already have{br}an account, enter your phone number

Let’s get started

You entered incorrect OTP {count} times. Please, enter your phone number again.

You entered incorrect PIN {attempts} times. Please, sign in again to reset the PIN.

Other locations

Popular locations

Enter PIN to login

{hasName, select, true {Welcome back, {name}} other {Welcome back}}

Incorrect PIN. You have {attempts} more attempts

Let’s set your PIN

Large cap

Market value from $500 million to $1 billion

Mid cap

Mega cap

Small cap

Exceptional income, but often associated with very high risk

10% and higher

Strong income, but comes with higher risk and potential volatility

5% and higher

Balanced income and stability, but moderate yields might not be high enough

2% and higher

May not satisfy income-focused investors, but offers steady growth potential

Up to 2%

High fees

Highest fees

Medium fees

Small fees

Medium cap

Titans

Price aligns with its expected value, neither cheap nor expensive

Fairly valued

Priced higher than its fundamentals suggest, might be seen as expensive

Overvalued

Significantly above its estimated value, could indicate inflated pricing

Strongly overvalued

Priced much lower than expected based on its fundamentals

Strongly undervalued

Lower than its estimated value, could suggest potential growth

Undervalued

If you weren't able to find an asset,{br}you may request it to add.

Nothing found

Something went wrong. Please, try again later.